BerandaUTHR • NASDAQ
add
United Therapeutics Corp
Tutup sebelumnya
$437,33
Rentang hari
$432,53 - $446,08
Rentang tahun
$266,98 - $479,50
Kapitalisasi pasar
19,17Â M USD
Volume Rata-Rata
713,84Â rb
Rasio P/E
16,86
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 799,50Â jt | 6,76% |
Biaya operasional | 309,30Â jt | 20,07% |
Penghasilan bersih | 338,70Â jt | 9,58% |
Margin laba bersih | 42,36 | 2,64% |
Penghasilan per saham | 7,16 | 1,25% |
EBITDA | 411,20Â jt | -3,77% |
Tarif pajak efektif | 22,67% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,77Â M | -16,80% |
Total aset | 7,35Â M | 3,20% |
Total liabilitas | 760,90Â jt | -25,56% |
Total ekuitas | 6,59 M | — |
Saham yang beredar | 43,06 jt | — |
Harga terhadap nilai buku | 2,85 | — |
Tingkat pengembalian aset | 12,76% | — |
Tingkat pengembalian modal | 14,14% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 338,70Â jt | 9,58% |
Kas dari operasi | 562,10Â jt | 49,02% |
Kas dari investasi | 140,90Â jt | 222,63% |
Kas dari pembiayaan | -956,00Â jt | -1.391,42% |
Perubahan kas bersih | -253,00Â jt | -227,65% |
Arus kas bebas | 157,44Â jt | -36,60% |
Tentang
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Didirikan
1996
Kantor pusat
Situs
Karyawan
1.305
